[1] Lefkowitz RJ, Willerson JT. Prospects for cardiovascular research[J]. JAMA, 2001, 285(5): 581-587. [2] 牛佳, 何书英, 李巍, 等. 肝素寡糖的制备及其对平滑肌细胞抗增生作用的初步研究[J]. 药物生物技术, 2009, 16(1): 46-49. [3] 刘亚梅, 何书英, 吴梧桐. 酶法制备低分子量肝素及其活性研究[J]. 药物生物技术, 2007, 14(4): 277-280. [4] 何书英, 孙程琛, 牛佳, 等. 一种肝素十二糖、其制法及其抗血管平滑肌细胞增殖的用途. 中国: 2010 10139398.9.2[P]. 2010-04-02. [5] 高丽丽, 唐咏春, 刘前, 等. 奥扎格雷钠联合低分子肝素治疗进展性脑梗死疗效观察[J]. 中国临床药理学与治疗学, 2008, 13(3): 336-338. [6] Zhao G, Shaik R, Zhao H, et al. Low molecular weight (LMW) heparin inhibits injury-induced femoral artery remodeling in mouse via upregulating CD44 expression[J]. J Vasc Surg, 2011, 5(53): 1359-1367. [7] Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s[J]. Nature, 1993, 362(6423): 801-809. [8] Ross R. Cell biology of atherosclerosis[J]. Annu Rev Physiol, 1995, 57: 791-804. [9] Faries PL, Rohan DI, Wyers MC, et al. Vascular smooth muscle cells derived from atherosclerotic human arteries exhibit greater adhesion, migration, and proliferation than venous cells[J]. J Surg Res, 2002, 104(1): 22-28. [10] Frank GD, Eguchi S. Activation of tyrosine kinases by reactive oxygen species in vascular smooth muscle cells: significance and involvement of EGF receptor transactivation by angiotensin II[J]. Antioxid Redox Signal, 2003, 5(6): 771-780. [11] Fei J, Viedt C, Soto U, et al. Endothelin-1 and smooth muscle cells: induction of jun amino-terminal kinase through an oxygen radical-sensitive mechanism[J]. Arterioscler Thromb Vasc Biol, 2000, 20(5): 1244-1249. |